Jostein Dahle
Chief Scientific Officer
Pharmaceutical technology
Jacobs Hanson and Co?LLC
New Zealand
Biography
Dr. Jostein Dahle, Ph.D. serves as Chief Scientific Officer (CSO) of Nordic Nanovector AS. He has been employed at the Company since January 2011. He has over 15 years of experience in cancer research. He comes from the position of Leader of the Radioimmunotherapy group at the Institute for Cancer Research at the Norwegian Radium Hospital. He holds a Doctorate of Philosophy degree in radiation biology from the University of Oslo from 2000 and a Master of Science degree in biophysics from the Norwegian University for Science and Technology in Trondheim from 1995. He is one of the Inventors of Betalutin, and has published over 40 papers in the field of cancer and biotechnology.
Research Interest
Nanomedicine Design of Nanodrugs Personalized Nanomedicine Nanomaterials for drug delivery
